SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 79.61 |
Enterprise Value ($M) | 82.19 |
Book Value ($M) | 13.85 |
Book Value / Share | 0.92 |
Price / Book | 5.75 |
NCAV ($M) | -2.62 |
NCAV / Share | -0.17 |
Price / NCAV | -30.42 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.94 |
Return on Assets (ROA) | -0.42 |
Return on Equity (ROE) | -0.61 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.32 |
Current Ratio | 3.20 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 47.15 |
Assets | 63.62 |
Liabilities | 49.77 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Huang James | 9.20 | 26.99 | |
13D/A | He Wei-Wu | 20.94 | 14.80 | |
13G | Venrock Healthcare Capital Partners III, L.P. | 9.99 | ||
13G | Foresite Capital Fund VI LP | 9.80 | ||
13D/A | Sparkle Byte Ltd | 7.60 | -90.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
4,435 | 16,006 | 27.71 | |
729 | 11,941 | 6.11 | |
6,250 | 62,675 | 9.97 | |
10,522 | 45,375 | 23.19 | |
1,418 | 18,654 | 7.60 | |
(click for more detail) |
Similar Companies | |
---|---|
CALC – CalciMedica, Inc. | CAPR – Capricor Therapeutics, Inc. |
CARA – Cara Therapeutics, Inc. | CDIO – Cardio Diagnostics Holdings, Inc. |
CDMO – Avid Bioservices, Inc. |
Financial data and stock pages provided by
Fintel.io